Variant report
Variant | nsv526712 |
---|---|
Chromosome Location | chr2:140870484-140880629 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:140877979..140880874-chr2:140883604..140885311,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LRP1B-2 | chr2:140873960-140874013 | XLOC_002340 |
2 | lnc-LRP1B-2 | chr2:140871611-140871673 | XLOC_002340 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542998276 | chr2:140871612-140871613 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs556674553 | chr2:140871613-140871614 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs576572700 | chr2:140871663-140871664 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs545056443 | chr2:140871672-140871673 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs552873920 | chr2:140873966-140873967 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs572830628 | chr2:140874021-140874022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575637005 | chr2:140874024-140874025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145769176 | chr2:140874129-140874130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561956867 | chr2:140874137-140874138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530131900 | chr2:140874198-140874199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543898533 | chr2:140874290-140874291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188004462 | chr2:140874334-140874335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532566143 | chr2:140874344-140874345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548951456 | chr2:140874347-140874348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567440577 | chr2:140874355-140874356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544965169 | chr2:140874369-140874370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537781383 | chr2:140874395-140874396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552875123 | chr2:140874447-140874448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566354302 | chr2:140874465-140874466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528828559 | chr2:140874493-140874494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548494817 | chr2:140874501-140874502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148500630 | chr2:140874507-140874508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574081929 | chr2:140874533-140874534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557037136 | chr2:140874563-140874564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12617016 | chr2:140874590-140874591 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs539026006 | chr2:140874653-140874654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552586968 | chr2:140874686-140874687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572789612 | chr2:140874720-140874721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542152037 | chr2:140874758-140874759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142773018 | chr2:140874776-140874777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs116073781 | chr2:140874832-140874833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192581832 | chr2:140874838-140874839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563793630 | chr2:140874846-140874847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376610569 | chr2:140874904-140874905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539975904 | chr2:140874930-140874931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs17468870 | chr2:140874933-140874934 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs546202747 | chr2:140874947-140874948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559833600 | chr2:140874948-140874949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538206334 | chr2:140874965-140874966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375662726 | chr2:140874971-140874972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548873207 | chr2:140874976-140874977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185418181 | chr2:140874996-140874997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs114604261 | chr2:140875089-140875090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550924490 | chr2:140875150-140875151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs188701189 | chr2:140875160-140875161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539189919 | chr2:140875180-140875181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs151045431 | chr2:140875216-140875217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12692035 | chr2:140875226-140875227 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs367847604 | chr2:140875259-140875260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368083187 | chr2:140875295-140875296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Mental retardation | 17621639 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
Ependymoma | 20639864 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:140874000-140875400 | Enhancers | Fetal Kidney | kidney |
2 | chr2:140875400-140876400 | Weak transcription | Fetal Kidney | kidney |
3 | chr2:140876200-140876800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr2:140876200-140877000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr2:140876200-140877000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr2:140876400-140876600 | Enhancers | Fetal Kidney | kidney |
7 | chr2:140876400-140876800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr2:140876400-140877000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr2:140876400-140877000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr2:140876400-140878400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr2:140876600-140877000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr2:140876800-140878000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
13 | chr2:140877000-140877600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
14 | chr2:140877000-140877600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
15 | chr2:140877600-140877800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr2:140877600-140877800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr2:140878000-140878400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr2:140879000-140879800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr2:140879400-140880400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |